Table 2.
Endpoint | MB | FB | Model | 95% CI | Final Effect | p | I2 (%) |
---|---|---|---|---|---|---|---|
ROM | 243 | 249 | Fixed | −4.37, −0.04 | −2.21 | 0.05 | 0 |
KSS | 487 | 548 | Random | −6.38, 5.64 | −0.37 | 0.9 | 99 |
KSFS | 176 | 241 | Fixed | −1.92, 0.31 | −0.81 | 0.2 | 0 |
OKS | 97 | 95 | Random | −11.56, 4.44 | −3.56 | 0.4 | 95 |
Revision | 2353 | 1148 | Random | 0.82, 3.20 | 1.62 | 0.2 | 52 |
Aseptic Loosening | 1810 | 658 | Random | 0.16, 7.96 | 1.12 | 0.9 | 89 |
Deep Infections | 1781 | 404 | Fixed | 0.28, 3.47 | 0.99 | 0.99 | 0 |
Fractures | 1679 | 277 | Random | 0.08, 4.85 | 0.61 | 0.6 | 62 |
OA Progression | 1752 | 602 | Fixed | 0.81, 2.60 | 1.45 | 0.2 | 3 |